Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Doxycycline versus placebo in pulmonary lymphangioleiomyomatosis
ACTRN12608000325303Phase 2Recruiting
- Sponsor
- Deborah H Yates
- Start
- Jan 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of doxycycline in lymphangioleiomyomatosis (LAM) (2 arms), sponsored by Deborah H Yates. Primary endpoints: Exercise capacity: 6 minute walk response, Quality of life and Visual Analogue Score dyspnoea scores and 1 more. Started Jan 2008; status: recruiting.
02
Drugs
doxycycline
03
Conditions
lymphangioleiomyomatosis (LAM)
Beyond the preview
Go deeper on ACTRN12608000325303.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12608000325303.